hit counter

REDDI MEG Classifier Separated 4 Neurodegenerative Diseases at 0.81

MHD featured image for REDDI MEG differential diagnosis research.

A 2026 medRxiv preprint found that REDDI, a resting-state magnetoencephalography machine-learning pipeline, separated mild cognitive impairment, multiple sclerosis, Parkinson’s disease, and amyotrophic lateral sclerosis with 0.81 ± 0.04 balanced accuracy across 5 folds.1 That is a meaningful jump over the prior 67.1% MEG benchmark, but it is still research-stage decision support rather than a clinical …

Read more

Antrodia Silver Nanoparticles Reduced Parkinsonism Markers in 63 Rats

MHD featured image for Antrodia silver nanoparticles and Parkinsonism oxidative-stress markers.

A 2026 Parkinsonism study involving 63 male rats found that Antrodia cinnamomea plus citrate-stabilized silver nanoparticles reduced 6-OHDA motor, oxidative-stress, inflammatory, α-synuclein, and apoptosis markers, while dopamine and acetylcholine recovery remained nonsignificant. The useful claim is a multitarget preclinical signal, not a Parkinson’s disease treatment recommendation. Research Highlights Combination treatment looked strongest: Tekiner et al. …

Read more

Alpha-Synuclein SAA Detected 95% of Lewy Body Dementia in ALZAN

MHD featured image for alpha-synuclein SAA and Lewy body dementia biomarkers.

A 2026 ALZAN memory-clinic cohort found that cerebrospinal-fluid alpha-synuclein seed amplification assay detected 19 of 20 Lewy body dementia cases, with 95% sensitivity and 93.5% specificity against non-Lewy-body, non-Alzheimer’s controls.1 The same assay was positive in 32 of 203 Alzheimer’s disease patients, which makes the result a co-pathology warning as much as a diagnostic win. …

Read more

Schizophrenia Risk Genes Reshape Microglial Pruning in CRISPR Screen

Stylized microglial cell engulfing synaptic material with CRISPR gene-editing elements, representing schizophrenia risk genes altering synaptic pruning.

Schizophrenia’s genetic architecture sits awkwardly between neurons and the immune system. A 2026 CRISPR screen of 30 schizophrenia-associated genes in human microglia-like cells found that several risk genes meaningfully alter how microglia engulf synaptic material, supporting the synaptic-pruning model at the functional gene level.1 Research Highlights 30 schizophrenia risk genes were knocked out one by …

Read more

Whole-Body Hyperthermia for Depression: IL-6 Heat Genes

Whole-body hyperthermia looks less like generic relaxation and more like a timed biological stressor: in a small depression substudy, a single session was followed by early Hamilton Depression Rating Scale improvement, heat-shock gene activation, and immune-process enrichment that included interleukin 6 production. Research Highlights Depression scores improved early: in the 18-person RNA sequencing substudy, whole-body …

Read more

Cholestatic Liver Injury Alters Thalamus Fatigue Genes

MHD featured image for cholestatic liver disease, thalamus changes, fatigue, and TNF signaling.

A 2026 mouse study linked cholestatic liver injury to smaller thalamic volume than control injury-free mice, broad thalamus gene-expression changes, and partial pathway rescue after systemic tumor necrosis factor neutralization. Research Highlights Thalamic volume decreased: bile duct ligation (BDL; a mouse model of obstructive cholestatic liver injury) reduced thalamic volume vs. sham surgery by magnetic …

Read more

Olfactory MRI Radiomics Link pTau217 to Alzheimer’s Cognition

MHD featured image for olfactory MRI radiomics, pTau217, and Alzheimer's disease cognitive impairment.

A 2026 multi-cohort Alzheimer’s disease study found that MRI radiomics from the hippocampus and amygdala linked plasma pTau217 and smell identification to cognitive impairment — with more added cognitive signal than simple regional volume. The result is useful because it points to a possible bridge between blood biomarkers and brain-circuit damage, but it is still …

Read more